Stock screenerAll disclosures →
EDGAR →
HUMA
Conviction 0HealthcareScan · Thu, Sep 24, 2026Humacyte, Inc. (HUMA) closed at $0.5665 (+0.14%) on Sep 24, 2026. Price is below its 50-day and below its 200-day moving average. RSI(14) 42, RS Rating 7, -77.2% from its 52-week high, -41.9% year to date. Sector: Healthcare · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES).
HUMA$0.5665+0.14%
ResistanceSupportVol 14Insider buyInsider sellCongress buyCongress sellVol MA14 3.42M
Jun 26Jul 15Aug 3Aug 19Sep 8Sep 24
Price0.5665
Change+0.14%
Gap-1.01%
Rel volume0.65×
Avg volume4.7M
Avg $ vol2.77M
SMA 200.5884
SMA 500.6332
SMA 2000.8952
Price vs 50-10.54%
Price vs 200-36.72%
MA stackbearish
50/200 cross—
Supertrenddown · 0.6648
RSI (14)42
MACD hist0.00
MACD crossbull · 4d
Stoch %K / %D38 / 45
ADX (14)15
+DI / −DI15 / 23
RSI divergence—
MACD divergence—
ATR %7.14%
ADR %5.63%
52w high2.48
52w low0.5500
From 52w high-77.16%
Above 52w low+3.00%
New 52w highNo
SqueezeOn · 1d
Bollinger width21.63%
%B0.33
Donchian pos15.76%
Donchian high0.7082
Donchian low0.5400
AVWAP (52w high)0.9712
vs AVWAP high-41.67%
AVWAP (52w low)0.6128
vs AVWAP low-7.56%
OBV trendDown
Chaikin MF (20)-0.36
Today vs 20d0.65×
Avg vol (14d)3.42M
Avg vol (20d)4.7M
Avg $ vol (20d)2.77M
Market cap157.37M
RS Rating7 / 99
RS 3m (vs SPY)-13.12%
RS 6m (vs SPY)-47.98%
RS line new highNo
Trend template0/8
Technical rank13.5
1 week-1.50%
1 month-19.21%
3 months-8.63%
6 months-31.17%
1 year-66.68%
YTD-41.90%
P/E-3.85
P/B5.03
P/S77.22
P/FCF-1.49
EPS-0.2600
Div yield—
ROE-130.62%
ROA-29.57%
Debt/Eq1.16
Current6.21
EV/EBITDA—
Gross margin—
Net margin—
Rev growth—
EPS growth72.54%
Price target—
Target upside—
Analyst rating—
Institutional—
Ent. value113.79M
Revenue406K
Net income-36.8M
Gross profit—
Free cash flow-105.93M
IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
ExchangeNasdaq
Shares out222.02M
Employees184
ListedFri, Aug 27, 2021
Free float196.53M
Float %88.5%
Short interest29.81M
Days to cover3.4d
Short volume69.1%
Squeeze score67 / 100
Next earnings—
EPS forecast—
Last EPS vs est−$0.16 vs −$0.10
Last surprise-60.0% miss
Setup gradeD
Conviction0 / 100
Pattern quality—
Tech rank13.5 / 100
Group rank59 / 100
Status lane—
Setup direction—
Pattern family
Resistance0.7500
Support0.5331
Days since event—
Candle confirm—
Financials as of Tue, Jun 30, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in HUMA · 10 recent
| Member | Side | Amount | Traded | Filed | PTR |
|---|---|---|---|---|---|
 Thomas H Tuberville senate · traded 2024-05-03 | Sell | $1K–$15K | 2024-05-03 | 2026-08-05 | |
Thomas H Tuberville senate · traded 2024-05-03 | Sell | $15K–$50K | 2024-05-03 | 2026-08-05 | |
Thomas H Tuberville senate · traded 2024-03-21 | Buy | $1K–$15K | 2024-03-21 | 2026-08-05 | |
Thomas H Tuberville senate · traded 2024-03-21 | Buy | $15K–$50K | 2024-03-21 | 2026-08-05 | |
Thomas H Tuberville senate · traded 2024-05-03 | Sell | $1K–$15K | 2024-05-03 | 2024-06-14 | |
Thomas H Tuberville senate · traded 2024-05-03 | Sell | $15K–$50K | 2024-05-03 | 2024-06-14 | |
Thomas H Tuberville senate · traded 2024-04-30 | Sell | $50K–$100K | 2024-04-30 | 2024-05-15 | |
Thomas H Tuberville senate · traded 2024-03-21 | Buy | $1K–$15K | 2024-03-21 | 2024-04-15 | |
Thomas H Tuberville senate · traded 2024-03-21 | Buy | $15K–$50K | 2024-03-21 | 2024-04-15 | |
Thomas H Tuberville senate · traded 2024-02-12 | Buy | $15K–$50K | 2024-02-12 | 2024-03-15 |
Insider activity
SEC Form 4 transactions in HUMA · open-market 5 buys · 2 sells
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Jones Keith Anthony Director · Common Stock · 2026-09-14 | Buy | 10K | $6K | 2026-09-14 | 2026-09-15 |
Jones Keith Anthony Director · Common Stock · 2026-08-20 | Buy | 10K | $7K | 2026-08-20 | 2026-08-21 |
Jones Keith Anthony Director · Common Stock · 2026-08-17 | Buy | 30K | $18K | 2026-08-17 | 2026-08-19 |
Bamforth John Philip Director · Stock Options (right to buy) · 2026-06-11 | Grant | 80K | — | 2026-06-11 | 2026-06-12 |
Sebelius Kathleen Director · Common Stock · 2026-05-19 | Buy | 56.82K | $50K | 2026-05-19 | 2026-05-20 |
Constantino Michael T. Director · Common Stock · 2026-05-18 | Buy | 11K | $10K | 2026-05-18 | 2026-05-20 |
Parikh Shamik J Chief Medical Officer · Common Stock · 2026-05-18 | Sell | 45.89K | $41K | 2026-05-18 | 2026-05-20 |
Sander Dale A. CFO and Chief Corp. Dev. Off · Common Stock · 2026-05-18 | Sell | 45.89K | $41K | 2026-05-18 | 2026-05-20 |
Sander Dale A. CFO and Chief Corp. Dev. Off · Common Stock · 2026-05-18 | Other | — | — | 2026-05-18 | 2026-05-20 |
SEC filings
EDGAR filings in HUMA · 10 recent
- 13D/GSCHEDULE 13D/ATue, Aug 18, 2026
- 10-K/Q10-QWed, Aug 12, 2026
- 8-K8-KWed, Aug 12, 2026
- 8-K8-KFri, Jul 31, 2026
- 13D/GSCHEDULE 13G/ATue, Jul 28, 2026
- 13D/GSCHEDULE 13D/AMon, Jul 13, 2026
- 13D/GSCHEDULE 13GMon, Jun 22, 2026
- 13D/GSCHEDULE 13D/AMon, Jun 15, 2026
- OFFER424B5Thu, Jun 11, 2026
- 8-K8-KThu, Jun 11, 2026
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.